ALT
Altimmune Inc.
Company Overview
| Mkt Cap | $358.32M | Price | $4.05 |
| Volume | 2.45M | Change | -0.49% |
| P/E Ratio | -3.8 | Open | $4.25 |
| Revenue | $20.0K | Prev Close | $4.07 |
| Net Income | $-95.1M | 52W Range | $2.90 - $11.16 |
| Div Yield | N/A | Target | $17.75 |
| Overall | 42 | Value | 40 |
| Quality | 42 | Technical | 45 |
No chart data available
Stock Overview
Updated DailyAltimmune Inc. (ALT) is a leading Healthcare company in the Biotechnology industry, currently trading at $4.05 with a market capitalization of $358.32 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows ALT with a volume of 2.45 million shares. The stock opened up 4.42% from yesterday's close of $4.07. Current analyst estimates project earnings of $-1.15 per share for this year, with next year targeting $-1.33.
ALT demonstrates strong technical indicators based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OMHE, OILS-CA, OGN, ONPH.
Key investment considerations for ALT include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 338.3%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 2, 2025 at 07:43 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALT | $4.05 | -0.5% | 2.45M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |